Difference of Surgical Site Infection Between Using Sodium Picosulfate Solution(PicosolutionⓇ) and Oral Sulfate Tablet(ORA·FANGⓇ) in Colorectal Cancer Surgery

• Status: Recruiting
• Trial end date: 2021-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective randomized study to evaluate the difference in the rate of surgical site infection between the patients who used Sodium Picosulfate solution(PicosolutionⓇ) and tablet Oral Sulphate Solution(ORA·FANGⓇ) for bowel preparation before colorectal cancer surgery .

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Cancer Center, Korea
• Collaborators: Daehang Hospital; Seoul National University Bundang Hospital; Seoul National University Hospital
• Treatments: Picosulfate sodium

Criteria

Inclusion Criteria:

1. Patients who are scheduled for an elective minimally invasive surgery for colorectal cancer

2. ASA score, 2 or less

Exclusion Criteria:

1. Bowel obstruction

2. FAP or IBD patients

3. Emergency operation

4. Pregnancy

5. Breast feeding

6. Severe medical condition such as severe cardiac,hepatic, or renal failure (creatinine ≥ 3.0 mg/dL (normal 0.8-1.4 mg/dL)),

7. Allergy to drug and refusal to participate in the study